TLDR
- Options traders are pricing in a near 12% move in BBWI stock following Q2 earnings on August 26
- Wall Street expects EPS of $0.24, down from $0.37 in Q2 last year, with revenue forecast at $1.5 billion
- BBWI stock is down nearly 2% year-to-date but up 8% over the last three months
- The stock has a 52-week range of $14.28 to $32.32 and a beta of 1.38
- Wall Street holds a Moderate Buy consensus with an average price target of $23.55, implying 23% upside
Bath & Body Works is set to report Q2 earnings on August 26, and the options market is bracing for a big reaction. Traders are pricing in a move of roughly 11.42%, either up or down, after the results drop.
BBWI stock is currently trading around $19.38. The stock is down nearly 2% year-to-date but has clawed back some ground, gaining about 8% over the past three months.
The company’s post-earnings history is a mixed bag. After its last report on May 27, 2026, the stock jumped 9.70%. But go back to the November 2025 report and it dropped 24.81%. Volatility is part of the BBWI story.
Wall Street is forecasting EPS of $0.24 for Q2, compared to $0.37 in the same quarter a year ago. Revenue is expected to come in at around $1.5 billion, just short of the $1.54 billion posted last year.
The company has missed Wall Street’s revenue estimates multiple times over the past two years, so analysts will be watching closely to see if that pattern continues.
What Analysts Are Watching
Revenue is expected to decline about 3.4% year over year this quarter. That’s a reversal from the 1.5% growth recorded in Q2 last year, and it sets a cautious tone heading into the print.
Analysts covering BBWI have broadly held their estimates steady over the past 30 days, suggesting no major surprises are expected. But the specialty retail space has been unpredictable lately.
Peers in the sector have had split results. Warby Parker posted 9.8% revenue growth but still fell 9.6% after earnings. Sally Beauty reported flat revenue and rose 10.6%. Investors in the space are on edge.
BBWI has been working to offset softer consumer demand. A new strategic partnership with Ulta Beauty is one move management has made to try to drive traffic and sales.
Consumer spending trends will be a key focus on the earnings call. Investors want to hear how management views the current buying environment heading into the back half of the year.
Wall Street’s View on BBWI
The consensus on TipRanks sits at Moderate Buy, based on 4 Buy ratings, 6 Holds, and 1 Sell. The average price target is $23.55, which implies about 23% upside from current levels.
The highest price target on the street is $30. That’s a long way from where the stock sits now, but it shows some analysts still see meaningful upside if the business steadies.
Bath & Body Works stock has traded between $14.28 and $32.32 over the past 52 weeks. Its beta of 1.38 means it tends to swing harder than the broader market, which lines up with the options market’s 12% implied move.
BBWI stock is heading into earnings down 5.4% over the past month, underperforming the specialty retail sector average, which is up 1.6% over the same period.
The average analyst price target stands at $25.33 against a current price of $19.38.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.







